2seventy bio, Inc. (TSVT)
NASDAQ
Market Cap
$124.84M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
85 of 951
Rank in Industry
65 of 544
Largest Insider Buys in Sector
TSVT Stock Price History Chart
TSVT Stock Performance
About 2seventy bio, Inc.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Insider Activity of 2seventy bio, Inc.
Over the last 12 months, insiders at 2seventy bio, Inc. have bought $4.1M and sold $442,137 worth of 2seventy bio, Inc. stock.
On average, over the past 5 years, insiders at 2seventy bio, Inc. have bought $5.1M and sold $524,213 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Casdin Capital, LLC (director) — $16.41M.
The last purchase of 40,000 shares for transaction amount of $203,992 was made by Casdin Capital, LLC (director) on 2024‑03‑26.
List of Insider Buy and Sell Transactions, 2seventy bio, Inc.
| 2025-01-07 | Sale | See Remarks | 186 0.0003% | $2.64 | $491 | -14.18% | ||
| 2025-01-06 | Sale | director | 892 0.0018% | $2.78 | $2,478 | -7.20% | ||
| 2025-01-06 | Sale | President and CEO | 763 0.0015% | $2.78 | $2,120 | -7.20% | ||
| 2025-01-06 | Sale | Chief Financial Officer | 97 0.0002% | $2.78 | $270 | -7.20% | ||
| 2025-01-06 | Sale | See Remarks | 5,114 0.0103% | $2.79 | $14,289 | -7.20% | ||
| 2025-01-03 | Sale | director | 85,978 0.1659% | $2.94 | $252,423 | -14.78% | ||
| 2025-01-03 | Sale | President and CEO | 31,718 0.0612% | $2.94 | $93,121 | -14.78% | ||
| 2025-01-03 | Sale | Chief Financial Officer | 1,013 0.002% | $2.94 | $2,974 | -14.78% | ||
| 2025-01-03 | Sale | See Remarks | 1,000 0.0019% | $2.94 | $2,936 | -14.78% | ||
| 2024-12-13 | Sale | See Remarks | 2,287 0.0044% | $3.23 | $7,393 | -10.09% | ||
| 2024-11-18 | Sale | director | 3,900 0.0076% | $3.38 | $13,182 | -8.88% | ||
| 2024-10-03 | Sale | Chief Financial Officer | 1,230 0.0023% | $4.65 | $5,718 | -18.84% | ||
| 2024-10-03 | Sale | See Remarks | 679 0.0013% | $4.65 | $3,157 | -18.84% | ||
| 2024-08-14 | Sale | See Remarks | 7,816 0.0156% | $4.32 | $33,760 | 0.00% | ||
| 2024-08-05 | Sale | Chief Financial Officer | 13 <0.0001% | $3.98 | $52 | +9.51% | ||
| 2024-07-02 | Sale | Chief Financial Officer | 12 <0.0001% | $4.02 | $48 | 0.00% | ||
| 2024-07-02 | Sale | See Remarks | 14 <0.0001% | $4.02 | $56 | 0.00% | ||
| 2024-06-03 | Sale | Chief Financial Officer | 1,167 0.0023% | $4.18 | $4,881 | +4.31% | ||
| 2024-06-03 | Sale | See Remarks | 649 0.0013% | $4.18 | $2,714 | +4.31% | ||
| 2024-05-03 | Sale | See Remarks | 15 <0.0001% | $4.91 | $74 | -7.37% |
Insider Historical Profitability
<0.0001%
| Casdin Capital, LLC | director | 2000000 3.8768% | $2.42 | 4 | 0 | |
| Leschly Nick | director | 1233606 2.3912% | $2.42 | 1 | 12 | <0.0001% |
| Baird William D III | President and CEO | 862126 1.6712% | $2.42 | 0 | 13 | |
| Eatwell Victoria | Chief Financial Officer | 338979 0.6571% | $2.42 | 0 | 6 | |
| Snow Jessica | See Remarks | 147179 0.2853% | $2.42 | 0 | 9 | |
| Maus Marcela V. | director | 23752 0.046% | $2.42 | 0 | 1 | |
| Kynam Capital Management, LP | 10 percent owner | 5953825 11.541% | $2.42 | 2 | 0 | |
| Kynam Global Healthcare Master Fund, LP | 10 percent owner | 5953825 11.541% | $2.42 | 1 | 0 | |
| Gregory Philip D | Chief Scientific Officer | 230842 0.4475% | $2.42 | 0 | 9 | |
| Heffron Nicola | Chief Operating Officer | 89182 0.1729% | $2.42 | 0 | 8 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Kynam Capital Management Lp | $31.85M | 11.58 | 5.95M | 0% | +$0 | 0.4 | |
| Morgan Stanley | $23.31M | 8.48 | 4.36M | -10.02% | -$2.6M | <0.01 | |
| Goldman Sachs | $22.59M | 8.21 | 4.22M | -6.37% | -$1.54M | <0.01 | |
| BlackRock | $20.89M | 7.6 | 3.91M | -0.16% | -$33,806.65 | <0.0001 | |
| The Vanguard Group | $19.96M | 7.26 | 3.73M | -6.38% | -$1.36M | <0.0001 | |
| Baker Bros Advisors LP | $13.36M | 4.86 | 2.5M | 0% | +$0 | 0.1 | |
| Madison Avenue Partners, LP | $13.02M | 4.73 | 2.43M | +38.66% | +$3.63M | 2.13 | |
| Casdin Capital | $10.7M | 3.89 | 2M | +69.12% | +$4.37M | 0.53 | |
| Healthcare Of Ontario Pension Plan Trust Fund | $9.29M | 3.38 | 1.74M | New | +$9.29M | 0.03 | |
| Point72 Asset Management | $8.63M | 3.14 | 1.61M | +360.94% | +$6.76M | 0.01 | |
| Engine Capital Management Lp | $7.99M | 2.91 | 1.49M | 0% | +$0 | 1.61 | |
| DAFNA Capital Management, LLC | $6.44M | 2.34 | 1.2M | -16.82% | -$1.3M | 0.16 | |
| Eversept Partners LP | $6.3M | 2.29 | 1.18M | +3.39% | +$206,333.44 | 0.49 | |
| Geode Capital Management | $6.12M | 2.22 | 1.14M | +4.97% | +$289,820.96 | <0.01 | |
| State Street | $5.35M | 1.95 | 1M | +2.35% | +$122,632.70 | <0.0001 | |
| JPMorgan Chase | $5.16M | 1.88 | 963,712 | -4.96% | -$269,126.39 | <0.0001 | |
| Cowen Group | $4.28M | 1.56 | 800,000 | 0% | +$0 | 0.14 | |
| Millennium Management LLC | $3.61M | 1.31 | 675,433 | -71.08% | -$8.88M | <0.01 | |
| Charles Schwab | $3.29M | 1.2 | 614,525 | -0.77% | -$25,626.50 | <0.01 | |
| Bank of America | $2.84M | 1.03 | 530,063 | +211.72% | +$1.93M | <0.0001 | |
| Marshall Wace | $2.37M | 0.86 | 443,615 | -60.03% | -$3.57M | <0.01 | |
| Northern Trust | $2.27M | 0.83 | 424,656 | +1.35% | +$30,275.65 | <0.0001 | |
| Jacobs Levy Equity Management | $2.03M | 0.74 | 379,586 | New | +$2.03M | 0.01 | |
| Venator Management Llc | $1.74M | 0.63 | 325,000 | +85.71% | +$802,500.00 | 0.52 | |
| Dimensional Fund Advisors | $1.23M | 0.45 | 229,216 | -6.68% | -$87,734.61 | <0.0001 | |
| Wellington Management Company | $1.08M | 0.39 | 202,073 | -60.84% | -$1.68M | <0.0001 | |
| BNY Mellon | $999,817.00 | 0.36 | 186,882 | -5.44% | -$57,501.70 | <0.0001 | |
| AQR Capital | $909,003.00 | 0.33 | 169,907 | -47.53% | -$823,413.65 | <0.01 | |
| Barclays | $892,000.00 | 0.32 | 166,722 | +99.54% | +$444,978.11 | <0.0001 | |
| Mirae Asset Global Investments Co Ltd | $1.35M | 0.29 | 146,901 | +85.99% | +$625,533.89 | <0.01 | |
| Susquehanna Fundamental Investments Llc | $739,600.00 | 0.27 | 138,243 | New | +$739,600.00 | 0.03 | |
| Prudential Financial | $576,281.00 | 0.21 | 107,716 | -11.65% | -$75,970.05 | <0.01 | |
| Invesco | $544,496.00 | 0.2 | 101,775 | +116.19% | +$292,634.17 | <0.0001 | |
| Nuveen | $519,908.00 | 0.19 | 97,179 | 0% | +$0 | <0.0001 | |
| Bridgeway Capital Management | $517,345.00 | 0.19 | 96,700 | 0% | +$0 | 0.01 | |
| HighVista Strategies | $500,225.00 | 0.18 | 93,500 | New | +$500,225.00 | 0.18 | |
| Fidelity Investments | $469,147.00 | 0.17 | 87,691 | +0.38% | +$1,765.50 | <0.0001 | |
| Wedmont Private Capital | $483,808.00 | 0.17 | 85,934 | New | +$483,808.00 | 0.04 | |
| RhumbLine Advisers | $436,878.00 | 0.16 | 81,662 | +2.03% | +$8,709.53 | <0.0001 | |
| Exchange Traded Concepts, LLC | $384,949.00 | 0.14 | 71,953 | +107.86% | +$199,753.18 | 0.01 | |
| American Century Investments | $366,957.00 | 0.13 | 68,590 | +51.27% | +$124,366.27 | <0.0001 | |
| HSBC | $364,849.00 | 0.13 | 68,196 | -7.48% | -$29,499.93 | <0.0001 | |
| State of Wisconsin Investment Board | $333,840.00 | 0.12 | 62,400 | New | +$333,840.00 | <0.01 | |
| UBS | $285,497.00 | 0.1 | 53,364 | -24.72% | -$93,731.87 | <0.0001 | |
| AllianceBernstein | $263,734.00 | 0.1 | 49,296 | -13.71% | -$41,890.56 | <0.0001 | |
| Citadel Advisors LLC | $259,571.00 | 0.09 | 48,518 | -65.81% | -$499,534.27 | <0.0001 | |
| Martingale Asset Management L P | $241,596.00 | 0.09 | 45,158 | New | +$241,596.00 | 0.01 | |
| Balyasny Asset Management Llc | $205,622.00 | 0.08 | 38,434 | New | +$205,622.00 | <0.01 | |
| Susquehanna International Group | $176,738.00 | 0.06 | 33,035 | -62.39% | -$293,159.84 | <0.0001 | |
| T. Rowe Price | $155,000.00 | 0.06 | 28,929 | +11.11% | +$15,500.54 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.